| Literature DB >> 33273363 |
Angelo Scuteri1,2, Athanasios Benetos3, Cristina Sierra4, António Coca4, Christian Chicherio5,6, Giovanni B Frisoni5,6, Dariusz Gasecki7, Dagmara Hering8, Dragan Lovic9, Efstathios Manios10, Mirko Petrovic11, Chengxuan Qiu12, Susan Shenkin13, Cristophe Tzourio14, Andrea Ungar15, Augusto Vicario16, Augusto Zaninelli17, Pedro G Cunha18,19.
Abstract
: The guidelines on hypertension recently published by the European Societies of Hypertension and Cardiology, have acknowledged cognitive function (and its decline) as a hypertension-mediated organ damage. In fact, brain damage can be the only hypertension-mediated organ damage in more than 30% of hypertensive patients, evolving undetected for several years if not appropriately screened; as long as undetected it cannot provide either corrective measures, nor adequate risk stratification of the hypertensive patient.The medical community dealing with older hypertensive patients should have a simple and pragmatic approach to early identify and precisely treat these patients. Both hypertension and cognitive decline are undeniably growing pandemics in developed or epidemiologically transitioning societies. Furthermore, there is a clear-cut connection between exposure to the increased blood pressure and development of cognitive decline.Therefore, a group of experts in the field from the European Society of Hypertension and from the European Geriatric Medicine Society gathered together to answer practical clinical questions that often face the physician when dealing with their hypertensive patients in a routine clinical practice. They elaborated a decision-making approach to help standardize such clinical evaluation.Entities:
Year: 2021 PMID: 33273363 DOI: 10.1097/HJH.0000000000002621
Source DB: PubMed Journal: J Hypertens ISSN: 0263-6352 Impact factor: 4.844